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Cytotoxicity of cisplatin and mitomycin C (MMC) is
ascribed largely to their ability to generate inter-
strand crosslinks (ICLs) in DNA, which block the
progression of replication forks. The processing of
ICLs requires the Fanconi anemia (FA) pathway, exci-
sion repair, and translesion DNA synthesis (TLS). It
also requires homologous recombination (HR), which
repairs double-strand breaks (DSBs) generated by
cleavage of the blocked replication forks. Here we
describe KIAA1018, an evolutionarily conserved
protein that has an N-terminal ubiquitin-binding
zinc finger (UBZ) and a C-terminal nuclease domain.
KIAA1018 is a 50/30 exonuclease and a structure-
specific endonuclease that preferentially incises
50 flaps. Like cells from FA patients, human cells
depleted of KIAA1018 are sensitized to ICL-inducing
agents and display chromosomal instability. The link
of KIAA1018 to the FA pathway is further strength-
ened by its recruitment to DNA damage through
interaction of its UBZ domain with monoubiquity-
lated FANCD2. We therefore propose to name
KIAA1018 FANCD2-associated nuclease, FAN1.INTRODUCTION
The Fanconi anemia (FA) pathway (Figure 1A) plays a key role in
interstrand crosslink (ICL) metabolism in higher eukaryotes by
coordinating S phase arrest and DNA repair (Moldovan and
D’Andrea, 2009; Thompson and Hinz, 2009). Replication fork
blockage activates the ataxia telangiectasia and RAD3-related
(ATR) kinase (Pichierri and Rosselli, 2004), which phosphorylates
members of the FA core complex (Meetei et al., 2003) composed
of FANCA, B, C, E, F, G, L, and FAAP100. The activated complex
then associates with FANCM-FAAP24, a DNA translocase (Gariet al., 2008), which activates the E3 ligase FANCL that subse-
quently ubiquitylates FANCD2-FANCI (Thompson and Hinz,
2009). The latter posttranslational modifications license the pro-
cessing of the blocked replication fork (Figure 1A), which
involves pausing of the fork, incision, lesion unhooking, transle-
sion DNA synthesis (TLS), and homologous recombination (HR)
(Moldovan and D’Andrea, 2009). FANCJ, a 50/30 DNA helicase,
appears to be involved in the late stages of ICL repair (Bridge
et al., 2005). Its action would give rise to 30 flaps, preferred
substrates of both endonucleases implicated in ICL processing
to date, MUS81/EME1 and XPF/ERCC1.
Recently, several laboratories found interaction between FA
proteins and polypeptides involved in mismatch repair (Peng
et al., 2007; Zhang et al., 2002). Our analysis of the MLH1 inter-
actome (Cannavo et al., 2007) identified FANCJ among the
strongest interactors. Another strong MLH1 interactor was
KIAA1018, a hypothetical protein predicted (Kinch et al., 2005;
Kosinski et al., 2005) to contain a RAD18-like ubiquitin-binding
zinc finger near its N terminus and a C-terminal endonuclease
domain. Given the importance of ubiquitylation in the FA
pathway (Moldovan and D’Andrea, 2009), and the fact that the
putative endonuclease domain of KIAA1018 belongs to the
same enzyme superfamily as those present in MUS81 and
XPF, we asked whether KIAA1018 is related to FA and how
mismatch repair (MMR) might be linked to this branch of DNA
repair. Hence, we decided to characterize KIAA1018 and to
study its role in DNA metabolism. We now show that KIAA1018
is a nuclease involved in the processing of mitomycin C
(MMC)- and cisplatin-induced DNA damage, to which it is
recruited by ubiquitylated FANCD2.
RESULTS
KIAA1018 Contains Evolutionarily Conserved Zinc
Finger and Endonuclease Domains
Analysis of MLH1 and PMS2 interactomes (Cannavo et al., 2007)
identified several peptides originating from the human KIAA1018
open reading frame (ORF), which encodes a polypeptide of 1017Cell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc. 77
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Figure 1. Schematic Representation of the FA Pathway and Evolu-
tionary Conservation of KIAA1018
(A) A consensus model of interstrand crosslink repair (Moldovan and
D’Andrea, 2009; Wang, 2007). Upon stalling of the replication fork, the FA
core complex is phosphorylated on several subunits by ATR and recruited to
the lesion by FANCM/FAAP24. This interaction activates the E3 ligase activity
of FANCL (a), which monoubiquitylates the FANCD2/FANCI heterodimer (b).
The fork is then cleaved by MUS81 on one side and unhooked by XPF/
ERCC1 on the other (c and d). Translesion polymerases then fill the gap oppo-
site the unhooked oligonucleotide (e), which is released by excision repair (f).
The collapsed replication fork is then rescued by the HR machinery, including
FANCD1 (BRCA2), FANCN (PALB2), and likely also FANCJ (f and g).
78 Cell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc.amino acids (aa). Its N-terminal region was predicted to contain
a RAD18-like CCHC zinc finger, a so-called UBZ domain,
present in proteins that bind ubiquitylated polypeptides (Hof-
mann, 2009). The C-terminal portion of KIAA1018 was sug-
gested to contain an endonuclease domain of the PD-D/E(X)K
type (Kinch et al., 2005; Kosinski et al., 2005) (Figure 1B).
Alignment of the aa sequences of human, murine, avian, and
C. elegans KIAA1018 revealed a high degree of evolutionary
conservation, particularly in the UBZ region (Figure 1C) and in
the putative endonuclease PD-D/E(X)K motif (Figure 1D), which
is found in other DNA repair proteins, such as the bacterial
MMR protein MutH, certain restriction enzymes, and, most
notably, the eukaryotic MUS81 and XPF/RAD1 endonucleases
(Figure 1E).
Depletion of KIAA1018 Sensitizes Human Cells
to Interstrand Crosslinking Agents
We asked whether KIAA1018 deficiency sensitizes cells to a
particular type of DNA damage. To this end, we knocked down
KIAA1018 mRNA in HEK293 cells by siRNA targeting exon 3
(Figure 2A) and subjected these cells to treatment with several
DNA-damaging agents. Compared to wild-type (WT) controls,
the KIAA1018 knockdown cells were not significantly sensitized
to X-rays (Figure 2B), UV irradiation (Figure 2C), or camptothecin
(Figure 2D). In contrast, KIAA1018-deficient cells were hypersen-
sitive to the ICL-inducing agents MMC (Figure 2E) and cisplatin
(Figure 2F), similarly to cells deficient in FANCJ (Figures 2A,
2E, and 2F). siRNA targeting exon 5 yielded similar results
(data not shown); the above phenotype was thus not caused
by an off-site effect of the siRNA.
KIAA1018 Requires Its Putative Nuclease Domain
for Activity
We generated HEK293 cell lines stably expressing KIAA1018
N-terminally fused to the green fluorescent protein (GFP). The
GFP-KIAA1018 fusion cDNAs encoded either the WT enzyme
or a variant carrying a D960A (DA) mutation in its predicted
nuclease active site. The cDNAs also contained silent mutations
in the KIAA1018 ORF, which made the respective mRNAs resis-
tant to knockdown by exon 3 siRNA. As shown in Figure S1A
(available online), the selected clones expressed similar levels
of the GFP-WT and GFP-DA variants. Treatment of these cells
with Luc siRNA did not affect their sensitivity to MMC. When
KIAA1018 siRNA was used, the sensitivity of the GFP-WT clone
was also unaffected, whereas the GFP-DA clones were sensi-
tized to MMC treatment (Figure 2G). This result confirms that
the phenotype induced by the KIAA1018 siRNA was not due to
an off-target effect, demonstrates that the GFP-WT fusion(B) KIAA1018 is a polypeptide of 1017 aa, containing a predicted N-terminal
RAD18-like CCHC zinc finger and a C-terminal endonuclease domain.
Alignments of the zinc finger (C) and endonuclease (D) domains of KIAA1018
from man, mouse, chicken, and worm are shown.
(E) Alignment of the endonuclease domain of human KIAA1018 with those of
human MUS81 and XPF and their yeast orthologs Mus81 and Rad1, respec-
tively. Identical residues are shown in bold. The key residues of the zinc finger
and endonuclease motifs are boxed. The numbers indicate aa residues flank-
ing these motifs in the respective KIAA1018 open reading frames. Asterisks
mark aa mutated to alanine (see Results).
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Figure 2. siRNA Knockdown of KIAA1018
Sensitizes Cells to MMC and Cisplatin
(A) Western blot showing efficacy of treatment with
the indicated siRNAs. Samples were collected 40
hr after siRNA transfection. siLuc served as nega-
tive control and b-tubulin as loading control.
(B–F) Clonogenic survival assays of HEK293 cells
treated 40 hr after siRNA-mediated KIAA1018
or FANCJ knockdown. KIAA1018-depleted cells
and mock-depleted controls were similarly sensi-
tive to X-rays (B), UV radiation (C), and camptothe-
cin (D). siRNA-mediated knockdown of KIAA1018
or FANCJ sensitized cells to MMC (E) and
cisplatin (F). Key: (A) siLuc; (-) siKIAA1018; (:)
siFANCJ.
(G) Clonogenic survival assay with HEK293 cells
stably expressing siRNA-resistant GFP-KIAA1018.
Cells expressing WT GFP-KIAA1018 showed
similar sensitivity to MMC, irrespective of depletion
of endogenous KIAA1018. In contrast, expression
of GFP-KIAA1018 D960A resulted in increased
sensitivity to MMC after depletion of endogenous
KIAA1018. Key: (A) GFP-KIAA1018 WT + siLuc;
(-) GFP-KIAA1018 WT + siKIAA1018; (:) GFP-
KIAA1018 D960A + siLuc; (X) GFP-KIAA1018
D960A + siKIAA1018. Graphs represent the results
of three independent experiments, each carried
out in triplicate. Each data point represents an
average ± standard deviation (SD).
(H) Increased embryonic lethality of C01G5.8
(tm423) mutant animals in response to cisplatin
treatment. (I) Rescue of C01G5.8(tm423) mutant
phenotype by C01G5.8::gfp expression. (J and K)
Embryonic lethality after treatment with UV or IR.
Synchronized L4 or opIs406(PC01G5.8::C01G5.8::
gfp::let-858(30UTR)) animals were exposed to
cisplatin for 24 hr (H and I) and were subsequently
allowed to lay eggs for 8 hr. For IR and UV treat-
ments (J and K), synchronized young adult animals
were allowed to lay eggs for 6–8 hr 24 hr post-treat-
ment. Embryonic lethality was quantified 24 hr
later. Data shown represent the average percent
embryonic lethality of 20 adult animals ± SD.
See also Figure S1.protein is functional, and, most importantly, shows that the
nuclease domain is indispensable for KIAA1018 function.
Disruption of the KIAA1018 Ortholog C01G5.8
in C. elegans Leads to Cisplatin-Induced Embryonic
Lethality
KIAA1018 is highly conserved in evolution (Figures 1C and 1D).
In order to ascertain that the above-described sensitivity to
ICL-inducing agents was not limited to KIAA1018-depleted
human cells, we examined the phenotype of C. elegans dis-
rupted in the KIAA1018 ortholog C01G5.8 (Figure S1B). The
C01G5.8(tm423) mutant developed similarly to WT (data not
shown), which showed that C01G5.8 is not required for normal
growth. Cisplatin treatment caused a dramatic increase in
embryonic lethality in the C01G5.8(tm423) mutants, whereas
the viability of WT worms was only slightly impaired (Figure 2H).
We next generated the transgenic C. elegans line opIs406
(PC01G5.8::C01G5.8::gfp) (Figure S1C). Like the human ortholog,the nematode GFP fusion protein overexpressed in this line
was functional, as it rescued the cisplatin-sensitive phenotype
of the C01G5.8(tm423) mutants (Figure 2I). Because treatment
with ultraviolet (UV) (Figure 2J) or ionizing radiation (IR)
(Figure 2K) had a similar effect on both WT and mutant animals,
we conclude that C01G5.8 functions in the repair of cisplatin-
induced damage during embryonic development. The sensitiza-
tion to cisplatin of both human cells and C. elegans lacking
KIAA1018 or its ortholog C01G5.8 suggests that the function of
this protein family in the processing of DNA damage is evolution-
arily conserved.
KIAA1018/C01G5.8 Localization to Subnuclear Foci
Is Enhanced by DNA Damage
As the GFP fusion proteins were functional, we decided to study
their localization. In actively proliferating cells, namely embryos
(Figures 3A and 3B) and germ cells of the mitotic region (Figures
3C and 3D), we observed both an evenly distributed as well asCell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc. 79
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Figure 3. KIAA1018 Is Recruited to Sites of
DNADamage inC. elegans andHumanCells
(A) C01G5.8 is a nuclear protein expressed in
embryos and in the germline of C. elegans.
C01G5.8::gfp was detected in the nucleus of
embryos (A and B), mitotic germline zone (C and
D), and late pachytene stage germ cells (E–J) of
the transgenic opIs406[PC01G5.8::C01G5.8::gfp::
let-858(30UTR)] line. Cisplatin treatment resulted
in relocalization of C01G5.8::gfp to distinct foci
(arrows) (H–J). Scale bars, 10 mm.
Human GFP-KIAA1018-WT colocalizes with
FANCD2 (K) and RPA (L) to MMC-induced foci.
U2OS cells stably expressing GFP-KIAA1018-
WT were mock-treated or treated with MMC
(120 ng/ml). After 20 hr, cells were stained with
antibodies against FANCD2 (TexasRed) (K) or
RPA (TexasRed) (L).fociform C01G5.8::gfp pattern. In contrast, in pachytene zone
germ cells, which are arrested in prophase of meiosis I,
C01G5.8::gfp was evenly distributed (Figures 3E–3G) but formed
foci upon cisplatin treatment (Figures 3H–3J).
Aggregation in subnuclear foci is a hallmark of proteins partici-
pating in DNA-damage response. As C01G5.8::gfp formed foci in
cisplatin-treated cells, we wanted to know whether human
KIAA1018 acted similarly. Untreated cells contained a small
number of foci of GFP-KIAA1018, FANCD2, and Replication
Protein A (RPA, marker of long stretches of single-stranded
DNA). Upon cisplatin (data not shown) and MMC treatment, the
number of foci rose dramatically, and GFP-KIAA1018 colocalized
in them with both FANCD2 (Figure 3K) and RPA (Figure 3L).
FANC Complex Signaling Is Unaffected
in KIAA1018-Depleted Cells
Given that sensitivity to ICL-inducing agents is a hallmark of FA
cells, and that KIAA1018 colocalizes to DNA-damage foci with
FANCD2, we suspected that KIAA1018 might be linked to the
FA pathway. We therefore asked whether KIAA1018 deficiency
affects activation of the FA complex, which can be detected as
monoubiquitylation of FANCD2 and FANCI (Garcia-Higuera80 Cell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc.et al., 2001; Smogorzewska et al., 2007).
As shown in Figure 4A, treatment of
HEK293 cells with MMC or hydroxyurea
(HU) resulted in substantial FANCD2
ubiquitylation, but this process was
unaffected by KIAA1018 knockdown.
A similar phenomenon was observed in
cells lacking FANCJ (Bridge et al., 2005).
Thus, if KIAA1018 were linked to the
FA pathway, it would—like FANCJ—act
downstream of the FA complex.
Human Cells Lacking FANCD2,
KIAA1018, or Both Proteins Display
Similar Sensitivities to MMC
Given that GFP-KIAA1018 and FANCD2
colocalize to DNA-damage-induced foci,we asked whether KIAA1018 and FANCD2 were epistatic.
We therefore knocked down KIAA1018 and FANCD2, either
singly or together, in HEK293 cells (Figure 4B). As shown in
Figure 4C, cells lacking both proteins were not appreciably
more sensitive to MMC than cells lacking only one of these poly-
peptides. This suggests that KIAA1018 might be epistatic with
the FA proteins, although a stable system is necessary to
exclude the possibility of an incomplete knockdown in cells
treated with both siRNAs.
The Zinc Finger of KIAA1018 Is Necessary and Sufficient
for Targeting the Protein to Sites of DNA Damage
KIAA1018 possesses a UBZ motif close to its N terminus (Figures
1B and 1C). In other polypeptides, this motif has been shown to
interact with ubiquitylated polypeptides (Hofmann, 2009). In
order to characterize the function of the UBZ of KIAA1018, we
expressed in E. coli glutathione S-transferase (GST) fused to
KIAA1018 aa 1–124 containing either the WT UBZ or a variant
in which the UBZ was disrupted by mutating cysteines 44 and
47 to alanines (Figure 1C). As zinc finger domains are also known
to bind DNA, we tested these peptides in a mobility shift assay,
using a homoduplex 38-mer oligonucleotide. We found no
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Figure 4. KIAA1018 Localization to MMC-
Induced Foci Requires Ubiquitylation and
FANCD2
(A) Western blot of extracts of HEK293 cells
treated or mock-treated with MMC (20 hr) or HU
(16 hr) 40 hr after transfection with the indicated
siRNAs. The treatments resulted in substantial
monoubiquitylation of FANCD2 in both experi-
ments, which shows that KIAA1018 acts down-
stream (or independently) of the FA complex. TFIIH
served as loading control.
(B) Western blot showing KIAA1018 and FANCD2
levels in HEK293 cells 40 hr after treatment with
the respective siRNAs. siLuc served as negative
control and TFIIH as loading control.
(C) siRNA-mediated knockdown of KIAA1018 or
FANCD2 sensitized cells to MMC to a similar
extent as a knockdown of both proteins. The
results of three independent experiments are
shown, each carried out in triplicate. Each data
point represents an average ± SD. Key: (A) siLuc;
(-) siKIAA1018; (:) siFAND2; (d) siKIAA1018 +
siFANCD2.
(D) U2OS cells stably expressing GFP-tagged full-
length KIAA1018-WT (top row), full-length zinc
finger CACA variant (second row), the N-terminal
124 amino acids of WT KIAA1018 containing the
zinc finger (third row), or the corresponding
CACA zinc finger fragment (bottom row) were
treated with 120 ng/ml MMC for 16 hr before
immunostaining with FANCD2 antibody. GFP foci
are only detectable in cells transfected with
vectors expressing KIAA1018 variants with an
intact UBZ domain.
(E) U2OS cells stably expressing GFP-KIAA1018-
WT were laser microirradiated and immunostained
2 hr later with an antibody against g-H2AX. Where
indicated, cells were incubated with 20 mM
MG132 for 120 min before irradiation. GFP-
KIAA1018 fails to be recruited to damage stripes
in the absence of ubiquitylation.
(F) U2OS cells stably expressing GFP-KIAA1018-
WT were treated with luciferase or FANCD2
siRNAs for 48 hr. Treatment with 120 ng/ml MMC
for 16 hr was followed by immunostaining with
anti-FANCD2 antibody. GFP-KIAA1018 is not re-
cruited to damage foci in the absence of FANCD2.
(G) PD20 (FA-D2) fibroblasts (top row), PD20 fibroblasts stably expressing FANCD2-WT (middle row), or FANCD2-K561R mutant (bottom row) were transiently
transfected with GFP-KIAA1018-WT, treated with 120 ng/ml MMC for 16 hr, and immunostained with anti-FANCD2 antibody. GFP-KIAA1018 only localizes to
damage foci in cells expressing the WT FANCD2 protein.
(H) Extracts of HEK293 cells stably expressing GFP-KIAA1018-WT or GFP-KIAA1018-CACA and treated with 120 ng/ml MMC were incubated with anti-GFP
antibody and the immunoprecipitate was analyzed with antibodies against GFP or FANCD2. GFP-KIAA1018 interacts preferentially with the monoubiqyitylated
form of FANCD2.
See Figure S2 for quantifications.evidence of the GST-fusions interacting with DNA in this assay,
even though the mismatch binding factor MutSa bound to the
homoduplex (a poor substrate for this protein) under identical
conditions (Figure S2A).
We then studied the MMC response of the GFP-KIAA1018
WT and CACA variants stably expressed in U2OS cells. We
generated two additional cell lines expressing solely the
N-terminal 124 aa residues encoding either the WT or the mu-
tant UBZ. Expression of these variants in U2OS cells, followed
by treatment with MMC, resulted in the formation of foci in cellsexpressing WT GFP-KIAA1018 and the 124 aa UBZ only. These
foci colocalized with those formed by FANCD2. In contrast,
both KIAA1018-CACA variants diffused throughout the nucleus
and failed to form foci upon MMC treatment, even though
FANCD2 foci formed normally (Figure 4D and Figure S2B).
siRNA-mediated knockdown of endogenous KIAA1018 in cells
expressing the KIAA1018 GFP-UBZ fragment did not alter
the targeting to the MMC-induced foci, thus excluding the
possibility that GFP-UBZ localizes to the damage sites via asso-
ciation with the endogenous protein (data not shown). ThisCell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc. 81
suggested that the UBZ is necessary and sufficient to target
GFP-KIAA1018 to DNA-damage foci generated by MMC
treatment.
Recruitment of KIAA1018 to DNA-Damage Foci
Is Dependent on FANCD2 Ubiquitylation
We wanted to know whether KIAA1018 targeting to MMC-
induced foci was dependent on ubiquitylation, similarly to that
described for FANCD2 (Garcia-Higuera et al., 2001). To this
end, we pretreated the U2OS cells stably expressing GFP-
KIAA1018 with MG132, an inhibitor of the 26S proteasome,
which also causes sequestration of ubiquitin in the cytoplasm
(Dantuma et al., 2006). We then generated DNA damage by
a UV microlaser, which induces a variety of DNA lesions concen-
trated in micron-thin stripes and causes a substantial perturba-
tion of chromatin structure, which brings about rapid recruitment
of the phosphorylated form of the histone variant g-H2AX.
As shown in Figure 4E and Figure S2C, GFP-KIAA1018 and
g-H2AX colocalized in the laser stripes, but the KIAA1018 signal
remained diffuse in MG132 pretreated cells. This indicated that
KIAA1018 recruitment to DNA damage in chromatin required
nuclear ubiquitin.
In the above experiments, we showed that MMC treatment of
U2OS cells stably expressing GFP-KIAA1018 induced the forma-
tion of KIAA1018 foci (Figures 3K and 3L), that FANCD2
colocalized with GFP-KIAA1018 to these foci (Figure 3K),
and that KIAA1018 was recruited to laser-induced stripes in
a ubiquitin-dependent manner (Figure 4E). As no KIAA1018 foci
were formed in cells in which FANCD2 mRNA was knocked
down with either one of two different siRNAs (Figures 4B and
4F, Figure S2D, and data not shown), we concluded that
KIAA1018 recruitment to DNA-damage foci required ubiquitin
and FANCD2.
This hypothesis could be further substantiated in the
FANCD2-mutated cell line PD20, which displayed no MMC-
induced foci of GFP-KIAA1018 (Figure 4G, top row; see also
Figure S2E). The phenotype of this cell line could be rescued
by expression of FANCD2 cDNA; in the latter cell line, FANCD2
and GFP-KIAA1018 colocalized to MMC-induced foci (Figure 4G,
middle row; Figure S2E). In contrast, when the cells were stably
transfected with a FANCD2 K561R variant that cannot be
ubiquitylated (Garcia-Higuera et al., 2001), both proteins failed
to form foci upon MMC treatment (Figure 4G, bottom row;
Figure S2E).
The above evidence strongly suggested that KIAA1018 is
recruited to MMC-induced foci by monoubiquitylated FANCD2,
likely in complex with FANCI. We therefore asked whether
KIAA1018 and FANCD2 interact directly. Using anti-GFP anti-
bodies, we immunoprecipitated the GFP-KIAA1018 fusion
protein, or its CACA UBZ variant, from extracts of stably trans-
fected, MMC-treated HEK293 cells, and probed the immunopre-
cipitates for the presence of FANCD2. As shown in Figure 4H, the
GFP antibodies pulled down WT GFP-KIAA1018 and both the
unmodified and the monoubiquitylated forms of FANCD2.
Notably, only the unmodified form was present in the GFP-
KIAA1018-CACA pull-down, which shows that KIAA1018 inter-
acts specifically with the monoubiquitylated form of FANCD2
via its UBZ domain.82 Cell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc.KIAA1018 Is a Nuclease
As bioinformatic analysis of the KIAA1018 ORF predicted the
protein to be an endonuclease (Kinch et al., 2005; Kosinski
et al., 2005), and given that the protein appears to protect cells
against ICL-generating substances, we asked whether the
protein is indeed a nuclease.
We expressed full-length KIAA1018 in E. coli fused to an
N-terminal Nus-His-tag (Ermolova et al., 2003) to aid solubility
and purified the fusion protein to apparent homogeneity (Figures
S3A and S3B). To test for nucleolytic activity, we deployed
a nonspecific endonuclease assay (Kadyrov et al., 2007). Incu-
bation of supercoiled plasmid DNA with increasing amounts of
the Nus-His-KIAA1018 fusion protein in the presence of manga-
nese and 100 mM KCl gave rise first to open circular, then linear
forms (Figure 5A, Figure S3C), showing that KIAA1018 cleaved
the substrate endonucleolytically. At the highest concentrations,
the linearized DNA was degraded, which suggested that the
enzyme is also an exonuclease. The UBZ-CACA variant was
similarly active as the WT enzyme, but the two variants carrying
mutations in the putative nuclease active site, D960A (DA) and
K977A (KA), were severely impaired at equal protein concentra-
tions (Figure 5A and Figures S3A–S3C). The loss of nuclease
activity of the latter two variants was apparently not linked to
incorrect folding or other structural perturbation, as the proteins
were still able to bind DNA in a gel shift assay (Figure S3D).
Most metal-dependent nucleases can be inhibited either by
chelating agents or by zinc or calcium. This is also true for
KIAA1018, which could be effectively inhibited by EDTA or by
zinc chloride (Figure 5B). The enzyme displayed optimal activity
at pH 7.2–7.4 and 25 mM KCl in the presence of manganese.
When magnesium was used, the endonucleolytic activity was
somewhat reduced, but the degradation of DNA was restricted
(Figure S3E). Under optimized conditions and when used in large
excess, the KA variant possessed residual nuclease activity in
the plasmid relaxation assay (Figure S3F). For this reason, we
decided to use the WT and the DA variant in the search for
specific substrates of KIAA1018.
KIAA1018 Preferentially Cleaves 50 Flaps and Has Both
Exo- and Endonuclease Activities
In the above experiments, to aid solubility we used bacterially
expressed KIAA1018 carrying a 55 kDa Nus-His tag. In order
to ensure that its activity was unaffected by the tag or by
the lack of posttranslational modifications, we expressed
KIAA1018 and its DA variant in the baculovirus system. An
N-terminal maltose-binding protein (MBP) tag was used to
express the protein, but this was removed during purification
(Figures S4A and S4B). We tested the untagged enzyme on
different oligonucleotide structures resembling intermediates of
replication and recombination (Figure S4C). We used magne-
sium as the divalent ion because proteins of the PD-(D/E)XK
nuclease superfamily are all magnesium dependent.
We first used substrates labeled at the 50 end of the top strand
(Figure S4C, f9) and could show that KIAA1018 cleaved them in
the following order of preference: 50 flap > > > splayed armz3-
way junction (3-WJ) > 30 flap. The principal products were frag-
ments between 31 and 35 nucleotides in length. As the flap
was 30 nucleotides long, this indicated that the enzyme cleaved
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Figure 5. KIAA1018 Is a Nuclease
(A) Twenty fmoles of plasmid DNA were incubated with increasing amounts of bacterially expressed Nus-His-KIAA1018. The WT protein and the CACA mutant
converted the supercoiled (sc) DNA first to open-circular (oc) and then to linear (lin) forms, whereas the DA and KA mutants did not. The figure is an image of an
ethidium bromide-stained 0.8% agarose gel. M: 1 kb marker (NEB), WT: Nus-His-KIAA1018-WT; DA: Nus-His-KIAA1018 mutant D960A; KA: Nus-His-KIAA1018
mutant K977A; CACA: Nus-His-KIAA1018 mutant C44AC47A; (–) no protein.
(B) Inhibition of KIAA1018 endonuclease activity with 2 mM EDTA or 2 mM ZnCl2. M: 1 kb marker, KIAA1018: WT. Assays were carried out in manganese buffer.
See Figure S3 for supplemental information.the substrates in double-stranded (ds) DNA, 1–5 nucleotides
downstream from the junction (Figure 6A and Figure S4C, large
arrow). In the reactions containing the 3-WJ, 30 flap, and, to
a small extent, also the splayed arm substrate, we also detected
very fast-migrating species, which corresponded in length to 2–4
nucleotides. This suggested that KIAA1018 is also a 50/30
exonuclease, as already anticipated from the preliminary assays
(Figure 5A). We could confirm this by labeling the same
substrates at the 50 end of the bottom strand (Figure 6A). In these
assays, all substrates gave rise to a pentamer fragment. (The
exonucleolytic cleavage products differed in length between
the substrates labeled in the top or the bottom strands because
the latter was one nucleotide longer. See Figure S4C.) This
shows that KIAA1018 can generate 50-recessed ends from
blunt-ended substrates and that the enzyme makes the first inci-
sion 4 nucleotides into the ds region on these substrates
(Figure S4C, small arrows). Interestingly, although the exonu-
clease activity of KIAA1018 on ds termini was robust, the
50 flap substrate was processed to yield predominantly the
single-stranded (ss) 31- to 35-mer flap and only small amounts
of the rapidly migrating species. This suggested that the enzyme
did not degrade the cleaved-off ss flap with appreciable effi-
ciency. We could confirm this by incubating the 50 flap substrate
with increasing amounts of enzyme. As shown in Figure 6B, the
amount of free ss flap fragments increased with enzyme concen-
tration, but only a minor increase in the high-mobility species
was observed.
Next we labeled the substrates at the 30 end. As shown in
Figure 6C, the 50 flap substrate gave rise to a series of bands
ranging in length from approximately 10–29 nucleotides, which
represent products of 50/30exonucleolytic degradation of the
labeled strand after the flap was cleaved off (Figure 6F). Interest-
ingly, while the 50-labeled 3-WJ (f9 strand) was cleaved with very
low efficiency (Figure 6A), the same substrate labeled at the30 end of the same (f9) strand appeared to be endonucleolytically
cleaved and then exonucleolytically degraded with efficiency
similar to the 50 flap. By 30-labeling the 30-mer (f7) of the 3-WJ,
we could show that this oligomer was rapidly degraded, creating
thus a 50 flap substrate that was then efficiently processed by
KIAA1018 (Figure 6D).
The bacterially expressed KIAA1018 used in comparable
amounts (Figure S4B) behaved in these assays similarly in
magnesium (data not shown) and in manganese (Figures S4D
and S4E). However, although manganese increased KIAA10180s
enzymatic activity, it decreased its specificity.
That the cleaved-off 50 flap (Figures 6A and 6B) was not further
processed by the enzyme is supported by the fact that ssDNA
was not appreciably bound by the enzyme in a gel shift assay,
whereas linear dsDNA, 50 flap and 30 flap substrates were bound
with similar efficiencies (Figure S4F).
In an attempt to study the substrate preference of KIAA1018
exonuclease, we incubated the enzyme with several different
substrates. As shown in Figure 6E and Figure S4G, KIAA1018
exonuclease activity displayed a clear preference for dsDNA
substrates containing a recessed 50 end, a nick, or a gap.
Blunt-ended DNA was processed less efficiently and the worst
substrates were ssDNA and ss 50 overhangs, as anticipated
from the stability of the cleaved-off 50 flap (Figure 6B).
To test whether the substrate specificity of KIAA1018 might be
altered by an as-yet-unidentified interacting partner, we immu-
noprecipitated the enzyme from HEK293 cells stably expressing
either FLAG-tagged KIAA1018 WT or the DA variant. The immu-
noprecipitate of the WT enzyme displayed the same substrate
preference as the bacterially expressed and the Sf9-expressed
proteins (Figures 6A and 6H, Figure S4D). However, it appeared
to be more specific, giving rise to a single product upon incuba-
tion with the 50 flap substrate (cf. product in Figure 6A). This
change was not due to MLH1, as coexpression of KIAA1018Cell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc. 83
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Figure 6. KIAA1018 Exhibits Preference for
50 Flaps
(A) Sf9-expressed KIAA1018-WT and its DA
variant were incubated with the indicated sub-
strates (protein to DNA ratio 10:1). KIAA1018
exhibits a preference for 50 flaps. Asterisk repre-
sents 32P phosphate.
(B) Incubation of WT KIAA1018 (3- to 10-fold
excess over DNA) with the 50 flap substrate for
1 hr at 37C. The ss product was resistant to
KIAA1018 exonuclease.
(C) DNA substrates used in (A) were labeled at the
30 end (see asterisks) to assess the exonuclease
activity of KIAA1018 (10:1 ratio protein to DNA).
Following endonucleolytic incision at the flap,
KIAA1018 degraded the remaining ds region
toward the 30 terminus of the 50 flap and 3-WJ
(see below).
(D) Time course of KIAA1018 incubation with the
indicated substrates (3:1 ratio protein to DNA).
Whereas the 50 flap was cut by KIAA1018 endonu-
cleolytically, the 3-WJ lost its 50 label due to
KIAA1018 exonuclease activity. The 30-mer oligo
of the 3-WJ is a good substrate for KIAA1018
exonuclease; its degradation gave rise to a 50
flap substrate, which was then endonucleolytically
cleaved by KIAA1018 (cf. panel A and Figure S4D).
Labeling of the 30 end of the 3-WJ showed also
weak 50/30 degradation of the top strand.
(E) KIAA1018 exonuclease preferentially degrades
dsDNA. Highest activity was observed on re-
cessed, nicked, or gapped DNA substrates (10:1
ratio protein to DNA), whereas ss DNA and 50 over-
hangs were poor substrates for KIAA1018.
(F) KIAA1018 incises 50 flaps and then degrades the
remaining strand in a 50/30 direction (20:1 ratio
protein to DNA). In this experiment, the 50 flap
substrate was labeled either at the 50 or the 30
end of the 60-mer oligonucleotide f9 (Figure S4C)
as indicated. The structures of the products are
shown at the side of the autoradiograph.
(G) Comparison of substrate preference of
KIAA1018, FEN1, and MUS81/EME1 (20:1 ratio
protein to DNA). FEN1 and KIAA1018 prefer 50
flaps, whereas MUS81/EME1 prefers 30 flaps. All
proteins were expressed in Sf9 cells.
(H) FLAG-KIAA1018 immunoprecipitated from
stably transfected HEK293 cells showed the
same specificity as the bacterially and Sf9-ex-
pressed recombinant KIAA1018 protein but
made a more defined cut at the DNA junction.
All assays shown in this figure were carried out in magnesium. Samples were separated on denaturing 20% polyacrylamide gels for 1 hr at 40V/cm. The radio-
active species were visualized by PhosphoImager (Typhoon 9400). M, oligonucleotide markers; WT, KIAA1018-WT; DA, KIAA1018 variant D960A. 3-WJ, 3-way
junction. See Figure S4 for supplemental information.with MLH1 did not affect the outcome of the nuclease assays
(data not shown). We are currently analyzing the interactome of
KIAA1018 in search for possible partners of this nuclease.
The substrate spectrum of KIAA1018 resembles that of FEN1,
which displays preference for 50 flaps (Harrington and Lieber,
1994). However, unlike KIAA1018, FEN1 made only a single
cut, at the end of the ss flap (Figure 6G). In contrast, MUS81/
EME1 failed to cleave the 50 flap substrate but showed a clear
preference for 30 flaps, as reported (Kaliraman et al., 2001). We
also included two D loop structures and a bubble in these exper-84 Cell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc.iments, as intermediates of recombination, but also as structures
that arise transiently during DNA replication and transcription,
processes blocked by cisplatin and MMC. Interestingly, the 50
flaps of the D loop proved to be processed by the KIAA1018
endonuclease activity with similar efficiency to the 50 flap,
whereas only the exonuclease acted on the bubble and the 30
flap substrates (Figure 6G, right panel).
The DA variant was used in parallel with the WT enzyme in the
above assays. As processing of the tested substrates was
almost undetectable (Figure 6, Figure S4), we conclude that
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Figure 7. KIAA1018 Is Involved in HR
U2OS cells were treated with Luc or KIAA1018
siRNAs for 40 hr. Treatment with 40 ng/ml MMC
(A, C, and D) or irradiation with 7 Gy (B and E)
was followed by immunostaining with anti-gH2AX
(A and B), anti-RPA (C), and anti-Rad51 (D and E)
antibodies at the indicated time points after treat-
ment. Graphs show % cells with more than five
foci. In three independent experiments, 50 cells
were counted per experiment. Each data point
represents an average ±SD. Western blot showing
efficiency of treatment with indicated siRNA for
(A)–(E).
(F) Depletion of KIAA1018 results in a partial
decrease of HR frequency compared to RAD51.
HEK293 DR-GFP cells were transfected with
siRNA against Luc (control), KIAA1018, and
RAD51. Forty hours later, transfection with an
I-SceI encoding plasmid or mock transfection
were performed, followed by flow cytometric
analysis 48 hr later. Approximately 1.1% of trans-
fected cells pretreated with siRNA against Luc
expressed GFP. Mock transfection did not result
in GFP-positive cells. Graph represents the results
of four independent experiments, each carried
out in triplicate. Each data point represents an
average ± SD.
(G–I) Depletion of KIAA1018 causes genomic
instability. (G) Metaphase spreads of siLuc or si-
KIAA1018 transfected HEK293 cells treated or
not with 25 ng/ml MMC for 20 hr were analyzed
for chromatid breaks (H) and radial structures (I).
Fifty spreads were analyzed per sample.
(J) Scheme of possible involvement of KIAA1018/
FAN1 in the processing of ICLs. See text for
details.both the exo- and the endonuclease activities are inherent to the
same active site of KIAA1018, rather than to a contaminant in the
purified fractions.
KIAA1018 Is Involved in the Repair of MMC-Induced
Double-Strand Breaks
As shown in Figure 1A, processing of ICLs was suggested to
involve endonucleolytic cleavage of the blocked replication forks
by MUS81/EME1 and/or XPF/ERCC1. These one-ended double-
strand breaks (DSBs) can be visualized directly by pulse-field gel
electrophoresis (De Silva et al., 2000; Hanada et al., 2006), or
indirectly as subnuclear foci of phosphorylated histone H2AX
(g-H2AX) (Niedernhofer et al., 2004; Rothfuss and Grompe,
2004). We wanted to test whether KIAA1018 depletion affectedCell 142,the formation and/or persistence of these
DSBs. As shown in Figure 7A, 12 hr after
MMC treatment, cells pretreated with
KIAA1018 or control siRNAs contained
6-fold more g-H2AX foci than untreated
controls. These foci reached a maximum
at the 24 hr time point and then began to
decline. This decline was substantially
slower in cells depleted of KIAA1018,
such that a considerable number ofg-H2AX foci were still present in the cells at the 96 hr time point.
However, the KIAA1018-deficient cells do not appear to have
a general defect in DSB repair, as treatment with IR induced
similar numbers of g-H2AX foci in cells pretreated with siRNA
against KIAA1018 and Luc control (Figure 7B).
KIAA1018 Deficiency Does Not Affect DSB Resection
but Causes Delay in the Disappearance of RPA Foci
Repair of DSBs is accomplished by one of two principal path-
ways: nonhomologous end-joining (NHEJ) and HR (West,
2003). DSBs arising through the processing of ICLs are thought
to be addressed predominantly by HR, whereby one strand of
the broken duplex has to be resected in a 50/30 direction to
generate long stretches of ssDNA. Given that KIAA1018 has77–88, July 9, 2010 ª2010 Elsevier Inc. 85
robust exonuclease activity, we wanted to find out whether it
might be required for resection. The ssDNA generated during
resection is coated first by RPA, and this process can be visual-
ized in the form of RPA foci. As shown in Figure 7C, we observed
a substantial increase of RPA foci in MMC-treated cells, but
these appeared with similar kinetics in cells pretreated with
siRNA against KIAA1018 and Luc. KIAA1018 thus does not
appear to be required for DSB resection. However, after 96 hr,
the RPA focus number returned nearly to untreated control
levels, whereas the siKIAA1018 pretreated cells still displayed
numerous foci.
KIAA1018 Is Involved in HR
During HR, RAD51 displaces RPA on the ssDNA to generate fila-
ments that invade homologous sequences on the sister chro-
matid (West, 2003). We analyzed the formation and disappear-
ance of RAD51 foci in MMC-treated cells, pretreated with
siRNA against KIAA1018 or Luc. We observed a 2- to 3-fold
increase in RAD51 foci already in untreated cells, but this differ-
ence became less prominent in MMC-treated cells at the 12 and
24 hr time points, when the number of foci reached a maximum.
However, at later time points, cells depleted of KIAA1018 con-
tained more than twice as many RAD51 foci as the control
(Figure 7D). This showed that KIAA1018 is not required for the
early HR steps, but rather for their completion. As in the case
of g-H2AX foci (Figure 7B), no appreciable difference in the
number of foci or the kinetics of their appearance and disappear-
ance could be seen in the KIAA1018 and Luc siRNA pretreated
cells upon irradiation (Figure 7E), which shows that the HR defect
is limited to events induced by MMC.
In order to confirm this hypothesis, we deployed the reporter
system described by Stark and colleagues (Bennardo et al.,
2008), which monitors successful recombination events
between two homologous DNA fragments integrated in the
genome of HEK293 cells. Both these fragments encode defec-
tive GFP and one carries an engineered recognition site for the
I-SceI endonuclease. Transfection of I-SceI cDNA into these
cells leads to cleavage of one of the GFP copies. Cells in which
the I-SceI-generated DSB is repaired by HR will express GFP. As
shown in Figure 7F, HR was almost entirely abolished in cells
pretreated with siRNA against RAD51, whereas siRNA against
KIAA1018 reduced the efficiency of HR in this system by
30%. This result confirms that KIAA1018 is involved in HR,
but its role in the rescue of DSBs that did not arise as intermedi-
ates of ICL processing appears to be minor.
KIAA1018 Deficiency Brings about Genomic Instability
Taken together, the evidence presented above implicates
KIAA1018 specifically in the processing of damage induced by
ICL-generating agents, which is one of the hallmarks of cells
from FA patients. The latter cells also display considerable chro-
mosomal instability (Akkari et al., 2000). Given the phenotypic
similarity of FA- and KIAA1018-deficient cells, the dependence
of KIAA1018 on FANCD2, and the above DSB repair defect, we
examined metaphase chromosome spreads in HEK293 cells
depleted either of KIAA1018 or of FANCJ by siRNA. As reported
by others (Bridge et al., 2005), we detected a notable increase
in chromosomal instability in FANCJ-depleted cells, where86 Cell 142, 77–88, July 9, 2010 ª2010 Elsevier Inc.several chromosomal aberrations were frequently seen in single
cells (data not shown). In KIAA1018-depleted cells, the chromo-
somal instability increase was much less pronounced. However,
we noted an increase in aberrations already in untreated cells,
and MMC treatment induced a 2-fold higher number of aberra-
tions in KIAA1018-depleted cells as compared to the control
siRNA pretreated cell population. Importantly, the increase in
radial chromosome formation was 5-fold higher than in the control
(Figures 7G–7I). Depletion of KIAA1018 thus brings about chro-
mosomal instability reminiscent of that seen in cells of FA patients.
DISCUSSION
As predicted by bioinformatic analysis (Kinch et al., 2005; Kosin-
ski et al., 2005), KIAA1018 is indeed a nuclease with both endo-
and exonuclease activities (Figure 5, Figure 6, Figure S3, and
Figure S4). Due to its association with FANCD2, we propose to
name it FAN1 (FANCD2-associated nuclease 1).
With its preference for 50 flaps, FAN1 displays an opposite
polarity to the two endonucleases implicated in ICL metabolism
to date, MUS81/EME1 and XPF/ERCC1, both of which cleave
preferentially 30 flaps (Figure 6G and Ciccia et al., 2008).
MUS81/EME1 is believed to initiate ICL repair by cleaving
the leading-strand template of the blocked replication fork
(Figure 1A, step c) and thus generate a one-ended DSB at the
fork. The subsequent ‘‘unhooking’’ of the lesion (Figure 1A,
step d) was proposed to involve XPF/ERCC1, but this is incon-
gruent with its preference for 30 flaps and is thus subject to
some controversy (Ciccia et al., 2008). Recently, Walter and
colleagues (Raschle et al., 2008) proposed an alternative mech-
anism of ICL repair, in which processing of the crosslink initiates
only when replication forks traveling in opposite directions
converge at the ICL (Figure 7J). In this scenario, FAN1 could
work in concert with the 30 flap-specific enzymes to unhook
the ICL by cleaving the lagging-strand template (Figure 1A and
Figure 7J, intermediate a) and thus help generate the substrate
for the TLS polymerases Rev1 and pol-z (Raschle et al., 2008),
which could later participate in the HR-mediated repair of the
DSBs (Figure 7J, intermediate b). FAN1 might be involved also
in the resolution of the HR intermediates. Although plausible,
this mechanism has two caveats. First, the small size of the
plasmid used made it likely that replication forks traveling in
opposite directions would reach the ICL almost concurrently.
This may not be the case in genomic DNA of higher eukaryotes,
where replication origins are far apart. Moreover, ICLs activate
a DNA-damage checkpoint that should prevent firing of late (or
dormant) origins and thus reduce the chances of two forks
colliding. The second caveat concerns the X-structure itself,
inasmuch as MUS81/EME1 and/or XPF/ERCC1 could cleave
both leading-strand templates of the X to generate two one-
sided DSBs and a linear, but crosslinked, intermediate (Figure 7J,
structure c). Both termini of this structure could be primer-
extended to generate a substrate for excision repair. In this
scenario, FAN1 would not be involved in the incision of the
blocked fork, although it might participate in the repair of the
two one-ended DSBs by HR (Figure 7J, intermediate d).
Data presented in Figure 7 support the involvement of FAN1
downstream from the replication fork cleavage. FAN1 deficiency
affected neither the formation of MMC-induced DSBs, as
measured by the appearance of g-H2AX foci (Figure 7A), nor
their resection, as evidenced by RPA and RAD51 foci formation
(Figures 7C and 7D respectively). However, it did affect DSB
repair. Thus, even though the reduction in HR efficiency as
measured by the GFP assay in HEK293 cells (Figure 7F) was
only slight, the disappearance of RAD51 foci in vivo was
substantially delayed (Figure 7D). Moreover, the chromosomal
breaks and radials observed in FAN1-depleted MMC-treated
cells strengthened the notion that FAN1 participates in HR and
that, in its absence, MMC-induced lesions are processed erro-
neously, possibly by NHEJ, to give rise to the observed aberra-
tions. Based on the above observations and coupled with
evidence showing that repair of DSBs induced by IR was unaf-
fected by FAN1 status, and that FAN1 depletion did not alter
the sensitivity of cells to IR and camptothecin (Figures 2B and
2D), as well as methyl methane sulfonate (MMS) and HU (data
not shown), we propose that FAN1 is required for the processing
of recombination intermediates that arise predominantly during
the metabolism of damage induced by ICL-generating agents.
The elucidation of the molecular role of FAN1 will have to await
the results of studies deploying a defined system, such as that
described by the Walter laboratory (Raschle et al., 2008).
Our findings that the recruitment of FAN1 to MMC-induced
foci is dependent on FANCD2 ubiquitylation, and that the two
proteins appear to physically interact, represent strong evidence
in support of an involvement of this nuclease in the FA-depen-
dent pathway of ICL repair. It remains to be seen whether
FAN1 is a FA gene. To date, FA patients fall into 13 complemen-
tation groups that are linked to mutations in the FANCA, B, C, D1,
D2, E, F, G, I, J, L, M, andN genes. However, several patients are
yet to be assigned, and we are in the process of screening the
DNA of these individuals for germline mutations in FAN1.
EXPERIMENTAL PROCEDURES
cDNA, vectors, antibodies, cell lines, protein purifications, and standard
procedures are described in Extended Experimental Procedures.
Immunofluorescence Staining and Laser-Induced Damage
U2OS cells cultured on coverslips were mock-treated or treated with
120 ng/ml MMC and fixed 16 or 20 hr later with 3% formaldehyde/PBS for
15 min at 4C. Membranes were permeabilized with 0.2% Triton X-100 in
PBS for 5 min at 4C. Samples were blocked with 3% nonfat milk/PBS and
incubated with primary antibodies overnight at 4C and with secondary anti-
bodies for 1 hr at 37C. DNA was stained with DAPI. Slides were analyzed
using an Olympus IX81 or a Zeiss LSM710 confocal microscope (sequential
scanning mode).
Ten micromoles of BrdU was added to the cells 24 hr prior to laser microir-
radiation. Laser stripes were induced with a laser beam (l = 355 nm) at 50%
power using the 403 objective. Cells were fixed 2 hr later.
siRNA Treatments and Cell Survival Assays
HEK293 cells were transfected with siRNAs in 6-well plates at 60% confluency
using calcium phosphate. For survival assays, cells were seeded 24 hr after
transfection in triplicates in 6-well plates at a density of 400 cells per well.
Sixteen hours after seeding, the cells were treated with indicated concentra-
tions of MMC, cisplatin, camptothecin, UV, or IR. Medium was replaced
24 hr (MMC and cisplatin), 1 hr (camptothecin), or directly (UV, IR) after treat-
ment. After 8 days, the cells were fixed and stained with 0.5% crystal violet in
20% ethanol and colonies containing more than 50 cells were counted.Specific Nuclease Assays
Endonuclease Assays
One nanomole of labeled substrate was incubated with 10 nmole (or as indi-
cated) of KIAA1018 WT or its variants in 25 mM HEPES-KOH (pH 7.4),
25 mM KCl, 1 mM MnCl2 or MgCl2 as indicated, and 0.05 mg/ml BSA for
30 min at 37C. The reaction was terminated with 0.1% SDS, 14 mM EDTA,
and 0.1 mg/ml Proteinase K and incubation at 55C for 15 min. Loading buffer
was added and the samples were separated on a 20% denaturing polyacryl-
amide gel for 1 hr at 40 V/cm. The gels were dried and the bands were visual-
ized on a PhosphoImager.
Exonuclease Assays
These were carried out as above, using the substrates indicated at the bottom
of the panels in Figure 6E and Figure S4G.
Endonuclease Assays with FLAG-KIAA1018 Immunoprecipitate
from HEK293 Cells
Stably transfected HEK293 cells expressing 33FLAG-KIAA1018 were grown
on 15 cm dishes with G418 to 80% confluency. The cells were pelleted by
centrifugation, washed in PBS, and snap-frozen. The pellets were lysed
(50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton, protease inhibitors) and
incubated on ice for 20 min. The lysate was centrifuged and incubated with
mouse anti-FLAG M2-Agarose (Sigma) for 2 hr at 4C on a rotating wheel
(300 rpm). Subsequently, the beads were washed twice for 15 min with
500 ml wash buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, and 1 mg/ml
BSA), then twice for 15 min with 500 ml with elution buffer (62.5 mM HEPES-
KOH pH 7.4, 62.5 mM KCl, 5% glycerol, and 1 mM DTT). FLAG-KIAA1018
was eluted with FLAG-peptides (150 ng/ml, Sigma) in a total volume of 70 ml
for 30 min at 4C on a shaker (600 rpm).
Homologous Recombination Assay
This was carried out essentially as described (Bennardo et al., 2008). Details
can be found in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
four figures and can be found with this article online at doi:10.1016/j.cell.
2010.06.022.
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